Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Patients with Endometrial Cancer in the SGO Clinical Outcomes Registry

Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infecti...

Full description

Saved in:
Bibliographic Details
Published inAnnals of surgical oncology Vol. 32; no. 5; pp. 3458 - 3464
Main Authors Yousif, Abdelrahman, Ngo, Julie, Abdel-Gadir, Deena, Rocconi, Rodney P., Timmins, Patrick, Lachance, Jason, Straughn, J. Michael, Dewdney, Summer, Lachance, Jenny, Mize, Benjamin, Chefetz, IIana
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.05.2025
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC. Patients and Methods We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables. Results A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open ( P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion ( P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent. Conclusions The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.
AbstractList Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC. We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables. A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent. The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.
Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC. Patients and Methods We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables. Results A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open ( P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion ( P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent. Conclusions The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.
BackgroundEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.Patients and MethodsWe queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects’ demographic and clinical variables.ResultsA total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.ConclusionsThe adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon’s choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.
Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.BACKGROUNDEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC management, conversion to laparotomy remains a concern due to the loss of laparoscopic benefits such as fewer surgical site infections and shorter hospital stays with reported rates varying widely. Factors influencing this conversion, including patient characteristics and tumor attributes, have not been fully understood. Our study aims to provide a framework for identifying patients at higher risk of conversion, thereby helping to inform surgical decision-making and patient counseling Addressing this gap, our study employs a national registry to analyze patient- and tumor-related factors associated with the transition from MIS to open surgery in EC.We queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables.PATIENTS AND METHODSWe queried the SGO Clinical Outcomes Registry (COR) to identify all patients with EC who underwent surgical management. The COR indeed validated clinical data from 29 sites collected between 2014 and 2018. The primary outcome was to assess the conversion rate from MIS to open surgery. Descriptive statistics using means with standard deviations or frequency with percentages were used. Chi-squared analysis was used to examine the bivariate relationship between group status and the subjects' demographic and clinical variables.A total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.RESULTSA total of 3.4% (135/4028) of patients underwent conversion from MIS to open surgery. Demographic characteristics were balanced between the groups. Conversion was more prevalent in patients with obesity (29%) and morbid obesity (37%) than in patients who are underweight (2%), normal weight (16%), and overweight (16%). Similarly, conversion was more prevalent in patients with prior abdominal surgery (63% versus 52%; P = 0.001). Endometrioid (EC) predominated (59%) in the converted group, with higher-than-expected non-endometrioid rates (serous carcinoma 16%, clear cell carcinoma 4%, carcinosarcoma 5%, mixed histology 12%; all P < 0.01). Advanced International Federation of Gynecology and Obstetrics (FIGO) stages were more common in patients who converted to open surgery (stage II: 5%, stage III: 25%, stage IV: 9%; all P < 0.001). Type II (24%) and type III (5%) hysterectomies were more frequent in patients who converted to open (P < 0.001). Logistic regression indicated body mass index (BMI), prior surgery, FIGO stage, histology, and hysterectomy type affected conversion (P < 0.001), explaining 12.3% of the variance in the conversion outcome. Indications for conversion included uterine size, adhesions, and disease extent.The adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.CONCLUSIONSThe adoption of MIS has become increasingly common standard of care for managing EC, attributed to enhanced perioperative outcomes. Factors associated with conversion such as uterine size, prior abdominal surgeries, surgical complexity, disease extent, and histologic types can affect the surgeon's choice. Ultimately, a personalized surgical approach, tailored to individual patient attributes, remains pivotal for optimizing outcomes in EC management.
Author Chefetz, IIana
Ngo, Julie
Straughn, J. Michael
Mize, Benjamin
Abdel-Gadir, Deena
Lachance, Jenny
Yousif, Abdelrahman
Timmins, Patrick
Dewdney, Summer
Lachance, Jason
Rocconi, Rodney P.
Author_xml – sequence: 1
  givenname: Abdelrahman
  surname: Yousif
  fullname: Yousif, Abdelrahman
  email: abdelrahman.yousif@ttuhsc.edu
  organization: OBGYN Department, Texas Tech University Health Sciences Center
– sequence: 2
  givenname: Julie
  surname: Ngo
  fullname: Ngo, Julie
  organization: Henry Ford Hospital Family Medicine Residency
– sequence: 3
  givenname: Deena
  surname: Abdel-Gadir
  fullname: Abdel-Gadir, Deena
  organization: College of Human Medicine, Michigan State University
– sequence: 4
  givenname: Rodney P.
  surname: Rocconi
  fullname: Rocconi, Rodney P.
  organization: University of Mississippi Medical Center
– sequence: 5
  givenname: Patrick
  surname: Timmins
  fullname: Timmins, Patrick
  organization: Women’s Cancer Care Associates
– sequence: 6
  givenname: Jason
  surname: Lachance
  fullname: Lachance, Jason
  organization: Maine Health
– sequence: 7
  givenname: J. Michael
  surname: Straughn
  fullname: Straughn, J. Michael
  organization: University of Alabama at Birmingham
– sequence: 8
  givenname: Summer
  surname: Dewdney
  fullname: Dewdney, Summer
  organization: Rush University Medical Center
– sequence: 9
  givenname: Jenny
  surname: Lachance
  fullname: Lachance, Jenny
  organization: Research Department, Hurley Medical Center, Michigan State University
– sequence: 10
  givenname: Benjamin
  surname: Mize
  fullname: Mize, Benjamin
  organization: Department of Gynecologic Oncology, Karmanos Cancer Institute, Wayne State University
– sequence: 11
  givenname: IIana
  surname: Chefetz
  fullname: Chefetz, IIana
  email: chefetz_i@mercer.edu
  organization: Department of Biomedical Sciences, Mercer University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39982547$$D View this record in MEDLINE/PubMed
BookMark eNp9ksluFDEQhlsoiCzwAhyQJS5cGrx3-4RGoxAiBQ1iOVtuT_WMo257sN2D-jl4YTyZEJYDJ1uu7_-rXFXn1YkPHqrqOcGvCeXiTSKYM15jKmoiFVf1_Kg6I6I8cdmSk3LHsq0VleK0Ok_pFmPSMCyeVKdMqZYK3pxVP5bB7yEmFzzqYxjRB-fdaIZhRtd-b5LbA_o8xY2zZkCL3S4GY7eQUA5otQN_F4M4o8UY_AZ9NNmBzwl9d3mLLv06jJCjK9Kl8RYich7lbXG8WqHlUDIdXFdTtoVL6BNsXMpxflo97s2Q4Nn9eVF9fXf5Zfm-vlldXS8XN7XlVOZa2F40qmulYL2ilkO3lh0nnDOC1xY4oZL2IJsGOkUxGGUYWLUurSFrAZ1gF9Xbo-9u6kYoEp-jGfQulgbEWQfj9N8R77Z6E_aaENVIxnFxeHXvEMO3CVLWo0sWhsF4CFPSrMyFtISpQ7KX_6C3YYq-_K9QrVKSNowX6sWfJT3U8mtgBaBHwMaQUoT-ASFYH7ZCH7dCl63Qd1uh5yJiR1EqsC_z-p37P6qfzku9Vg
Cites_doi 10.1001/jama.2017.2068
10.1016/j.ajog.2019.05.004
10.1016/j.ejso.2019.11.519
10.1016/j.ygyno.2022.06.004
10.1007/s00404-019-05393-5
10.1016/j.clon.2021.05.001
10.7150/ijms.52293
10.1200/JCO.2009.22.3248
10.1007/s10147-020-01744-4
10.1016/j.ygyno.2018.01.021
10.1097/IGC.0000000000000594
10.1016/j.ygyno.2014.06.008
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
Copyright Springer Nature B.V. May 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: Copyright Springer Nature B.V. May 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
H94
K9.
7X8
5PM
DOI 10.1245/s10434-025-16949-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-4681
EndPage 3464
ExternalDocumentID PMC11976340
39982547
10_1245_s10434_025_16949_y
Genre Journal Article
GroupedDBID ---
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
199
1N0
1SB
203
23M
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2WC
2~H
30V
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6J9
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDZB
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYFIA
AZFZN
B-.
BA0
BAWUL
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
C1A
C6C
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DIK
DL5
DNIVK
DPUIP
E3Z
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GRRUI
GXS
H13
HEOXT
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IH2
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
OWW
P19
P2P
P9S
PF0
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOQ
YFH
YLTOR
Z45
ZMTXR
ZOVNA
AAYXX
ABFSG
ACMFV
ACSTC
AEZWR
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
7TO
ABRTQ
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c426t-5cf579b8653f92c4ebd6b4144310dce41262fe677eb920ea9a3ec9d6811d5eb53
IEDL.DBID C6C
ISSN 1068-9265
1534-4681
IngestDate Thu Aug 21 18:35:51 EDT 2025
Fri Jul 11 07:26:41 EDT 2025
Sat Aug 16 19:51:30 EDT 2025
Thu Apr 24 02:14:19 EDT 2025
Tue Jul 01 05:12:30 EDT 2025
Thu Apr 10 07:49:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Minimally invasive surgery
Prior abdominal surgery
Endometrial cancer
Anemia
Uterine size
Chemoresistance
Hysterectomy
Conversion
Blood transfusion
Open surgery
Risk factors
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c426t-5cf579b8653f92c4ebd6b4144310dce41262fe677eb920ea9a3ec9d6811d5eb53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doi.org/10.1245/s10434-025-16949-y
PMID 39982547
PQID 3189962734
PQPubID 32486
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11976340
proquest_miscellaneous_3169181395
proquest_journals_3189962734
pubmed_primary_39982547
crossref_primary_10_1245_s10434_025_16949_y
springer_journals_10_1245_s10434_025_16949_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-05-01
PublicationDateYYYYMMDD 2025-05-01
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
– name: New York
PublicationTitle Annals of surgical oncology
PublicationTitleAbbrev Ann Surg Oncol
PublicationTitleAlternate Ann Surg Oncol
PublicationYear 2025
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References G Scaletta (16949_CR3) 2020; 46
N Jones (16949_CR7) 2014; 134
NR Kim (16949_CR11) 2022; 166
K Matsuo (16949_CR10) 2016; 26
A Papadia (16949_CR14) 2020; 301
SI Kim (16949_CR13) 2021; 18
C Uwins (16949_CR2) 2021; 33
M Janda (16949_CR5) 2017; 317
JL Walker (16949_CR6) 2009; 27
SB Dewdney (16949_CR8) 2018; 148
G Scaletta (16949_CR12) 2020; 46
MC Cusimano (16949_CR4) 2019; 221
16949_CR1
T Tanaka (16949_CR15) 2020; 25
C Lönnerfors (16949_CR9) 2013; 78
References_xml – volume: 317
  start-page: 1224
  issue: 12
  year: 2017
  ident: 16949_CR5
  publication-title: JAMA.
  doi: 10.1001/jama.2017.2068
– volume: 221
  start-page: 410
  issue: 5
  year: 2019
  ident: 16949_CR4
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2019.05.004
– volume: 46
  start-page: 782
  issue: 5
  year: 2020
  ident: 16949_CR12
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2019.11.519
– volume: 166
  start-page: 236
  issue: 2
  year: 2022
  ident: 16949_CR11
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2022.06.004
– volume: 46
  start-page: 782
  issue: 5
  year: 2020
  ident: 16949_CR3
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2019.11.519
– volume: 301
  start-page: 585
  issue: 2
  year: 2020
  ident: 16949_CR14
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-019-05393-5
– volume: 33
  start-page: e372
  issue: 9
  year: 2021
  ident: 16949_CR2
  publication-title: Clin Oncol (R Coll Radiol)
  doi: 10.1016/j.clon.2021.05.001
– volume: 18
  start-page: 1153
  issue: 5
  year: 2021
  ident: 16949_CR13
  publication-title: Int J Med Sci
  doi: 10.7150/ijms.52293
– volume: 27
  start-page: 5331
  issue: 32
  year: 2009
  ident: 16949_CR6
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.22.3248
– volume: 25
  start-page: 1985
  issue: 11
  year: 2020
  ident: 16949_CR15
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-020-01744-4
– volume: 78
  start-page: 12
  issue: 1
  year: 2013
  ident: 16949_CR9
  publication-title: Ceska Gynekol
– volume: 148
  start-page: 439
  issue: 3
  year: 2018
  ident: 16949_CR8
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2018.01.021
– volume: 26
  start-page: 290
  issue: 2
  year: 2016
  ident: 16949_CR10
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0000000000000594
– volume: 134
  start-page: 238
  issue: 2
  year: 2014
  ident: 16949_CR7
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2014.06.008
– ident: 16949_CR1
SSID ssj0017305
Score 2.4629333
Snippet Background Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have...
Endometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have revolutionized EC...
BackgroundEndometrial cancer (EC) ranks as the most common gynecologic malignancy in the USA. While minimally invasive surgical (MIS) techniques have...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3458
SubjectTerms Adult
Aged
Body mass index
Body weight
Carcinoma
Clinical outcomes
Conversion to Open Surgery - statistics & numerical data
Decision making
Demography
Endometrial cancer
Endometrial Neoplasms - pathology
Endometrial Neoplasms - surgery
Endometrium
Female
Follow-Up Studies
Gynecologic Oncology
Gynecology
Histology
Humans
Hysterectomy
Invasiveness
Laparoscopy
Laparoscopy - methods
Malignancy
Medicine
Medicine & Public Health
Middle Aged
Minimally invasive surgery
Minimally Invasive Surgical Procedures - methods
Obesity
Obstetrics
Oncology
Patients
Prognosis
Registries - statistics & numerical data
Statistical analysis
Surgery
Surgical Oncology
Surgical site infections
Tumors
Underweight
Uterine cancer
Uterus
Title Conversion from Minimally Invasive Surgical Approaches to Open Surgery Among Patients with Endometrial Cancer in the SGO Clinical Outcomes Registry
URI https://link.springer.com/article/10.1245/s10434-025-16949-y
https://www.ncbi.nlm.nih.gov/pubmed/39982547
https://www.proquest.com/docview/3189962734
https://www.proquest.com/docview/3169181395
https://pubmed.ncbi.nlm.nih.gov/PMC11976340
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD6CTUK8IO5kjOkg8QaRGt8SP2ZRuwHqhhiVxlNkJ-6o1KWol0n9HfxhfJy0UAYPvCQPtpzE37HzHZ8bwJukzirBbBqPVaVjkfVMrLnVceYEr7TSWR2KTQzP1OlIfLiUl12aHIqF-d1-z4SkEDfBRUxFVxOlhY7Xd2FfJjylMg2FKrYWAy-pMlg2lV_ATMkuQObvY-z-hG4xy9sOkn9YScPPZ_AQHnSsEfMW5kdwxzWP4d6ws4s_gR8FOY-Hky-kgBEcTprJtZlO1_i-uTHkoo4Xq3nY5TDv0oi7BS5nSB4loc3N15hT6SH81OZaXSAd0mK_qWfXLlT3wIJkZI6TBj1vxIuTc-zyik7xfLX0wuvH_OyuQgW5pzAa9L8Up3FXbiH2aKllLKuxTLXNlORjzSrhbK2s8AqXZ4B-JkTCFBs7labOatZzRhvuKl2rLElq6azkz2CvmTXuBaDK6sxZTwWtsYLXlTHceL2RmUS5mqdVBG83819-b7NqlKSNeLTKFq3So1UGtMp1BIcbiMpuhS1KvxdpKhzERQSvt81-bZDBwzRutqI-SnsGw7WM4HmL6PZxnpiRcpxGkO1gve1Aebd3W5rJt5B_myyvioteBO82YvHrvf79GQf_1_0l3GckssG58hD2lvOVe-UJ0NIewX4-OD4-o_vJ14_9o7AS_HXE8p-gzwQf
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD6CIcFeJu4LDDhIvEGkJr7EfqyqjQ7WDbFV2ltkJy6r1KVTmyL1d-wPc-wkRWXwwLMtJ_F3jv2dnBvAh6RUBU9tFk9koWOueibWzOpYOc4KLbUqQ7OJ0akcjvmXS3HZJoUtu2j3ziUZTupQAYELn-zGGY99-9VEaq7j9X14QGRAeVkep_2N74BkVgQfpyRVTqVoU2X-vsb2dXSHY94NlfzDXxquoaPHsNfyR-w3gD-Be656Cg9HrYf8GdwOfBh5-AeGPnUER9Nqem1mszUeVz-ND1bH89UinHfYbwuKuyXWc_SxJWHMLdbY902I8FtTdXWJ_nctHlbl_NqFPh848NKywGmFxCDx_PMZthVGZ3i2qmlHac3v7kfoJfccxkeHF4Nh3DZeiAk3WceimIhMWyUFm-i04M6W0nIyvYgL0k7wJJXpxMksc1anPWe0Ya7QpVRJUgpnBXsBO9W8cvuAUpXKWSKF1ljOysIYZsiCTE0iXcmyIoKP3f7nN019jdzbJYRW3qCVE1p5QCtfR3DQQZS3urbM6VTSvoUQ4xG83wyTlnjXh6ncfOXnSE1chmkRwcsG0c3jiKJ5MzmLQG1hvZngK3Bvj1TTq1CJ2_tgJeO9CD51YvH7vf79Ga_-b_o7eDS8GJ3kJ8enX1_DburFN4RcHsBOvVi5N0SLavs2aMEvf5MHPQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_BkCZeEN8LDDASbxDRxB-xH6uwsgHdJsakvUV27EClzp3aFKl_B_8wPictlMEDz7acxL87-y539zuAV5mVNctNkTaiVimTA50qalQqHaO1Ekra2GxifCwOz9mHC37xWxV_zHZfhyS7mgZkafLt2yvbdGwIjGPhG6MsxVasmVBMpaubcCt4Khm6X6UoN3GEIL88xjtFUOtc8L5s5u9rbF9N1-zN62mTf8RO45U0ugt3eluSDDvw78EN5-_D7riPlj-AHyWmlMf_YQTLSMh44ieXejpdkSP_XWPiOjlbzuPZR4Y9ubhbkHZGMM8kjrn5igyxIRE57RhYFwR_3ZIDb2eXLvb8ICVKzpxMPAnWJDl7f0J6ttEpOVm2YXfDmp_d19hX7iGcjw6-lIdp34QhDRiKNuV1wwtlpOC0UXnNnLHCsOCGBbsw7ATLcpE3ThSFMyofOK00dbWyQmaZ5c5w-gh2_My7PSBCWulMMBCNNozaWmuqgzeZ60w4S4s6gdfr_a-uOq6NCn2UgFbVoVUFtKqIVrVKYH8NUdXr3aIKJ5TCdkKUJfByMxw0BsMg2rvZEucIFewaqngCjztEN48L5hq6zEUCcgvrzQRk494e8ZNvkZUb47GCskECb9Zi8eu9_v0ZT_5v-gvYPX03qj4dHX98CrdzlN6YfbkPO-186Z4FC6k1z6MS_AQW6Qtj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conversion+from+Minimally+Invasive+Surgical+Approaches+to+Open+Surgery+Among+Patients+with+Endometrial+Cancer+in+the+SGO+Clinical+Outcomes+Registry&rft.jtitle=Annals+of+surgical+oncology&rft.date=2025-05-01&rft.pub=Springer+Nature+B.V&rft.issn=1068-9265&rft.eissn=1534-4681&rft.volume=32&rft.issue=5&rft.spage=3458&rft.epage=3464&rft_id=info:doi/10.1245%2Fs10434-025-16949-y&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon